Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028

Global Beta-Nicotinamide Mononucleotide (NMN) Market Insights, Forecast to 2028

Industry: Pharma & Healthcare

Published: 2022-06-28

Pages: 141 Pages

Report ld: 366851

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Market Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market
The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.

Global Beta-Nicotinamide Mononucleotide (NMN) Scope and Segment
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company 
  GeneHarbor
  Herbalmax
  Genex Formulas
  Shinkowa Pharmaceutical
  Maac10 Formulas
  EffePharm
  Bontac
  CELFULL
  Kingdomway

Segment by Type
  Content ≥98%
  Content ＜98%

Segment by Application
Health Care Products
  Cosmetics
  Others

Segment by Region
North America
  U.S.
  Canada

  Asia-Pacific
  China
  Japan
  Korea
  India
  Australia
  Southeast Asia

  Europe
  Germany
  France
  U.K.
  Italy
  Russia

  Latin America
  Mexico
  Brazil
  Argentina

  Middle East and Africa
  Middle East
  Africa

 1 STUDY COVERAGE 1
    1.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1
    1.2 Market by Type 1
    1.3 Market by Application 2
        1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2
        1.3.2 Health Care Products 3
        1.3.3 Cosmetics 4
    1.4 Study Objectives 4
    1.5 Years Considered 5

 2 EXECUTIVE SUMMARY 6
    2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6
    2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7
    2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8
    2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9
        2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9
        2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10
    2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12
        2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12
        2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12
    2.6 North America 13
    2.7 Europe 14
    2.8 Asia-Pacific 15
    2.9 Latin America 16
    2.10 Middle East and Africa 17

 3 COMPETITION BY MANUFACTURERS 19
    3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19
        3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19
        3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20
        3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21
    3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21
        3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21
        3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22
        3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23
    3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23
    3.4 Analysis of Competitive Landscape 24
        3.4.1 Manufacturers Market Concentration Ratio (CR5) 24
        3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
        3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25
    3.5 Mergers & Acquisitions, Expansion Plans 26

 4 MARKET SIZE BY TYPE 27
    4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27
        4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27
        4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27
        4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27
    4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28
        4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28
        4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29
        4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29
    4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30
        4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30
        4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30

 5 MARKET SIZE BY APPLICATION 32
    5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32
        5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32
        5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32
        5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33
    5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34
        5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34
        5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34
        5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34
    5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36
        5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36
        5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36

 6 NORTH AMERICA 37
    6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37
        6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37
        6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38
    6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39
        6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39
        6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40
    6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42
        6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42
        6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43
        6.3.3 U.S. 44
        6.3.4 Canada 45

 7 EUROPE 46
    7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46
        7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46
        7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47
    7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48
        7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48
        7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49
    7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51
        7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51
        7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52
        7.3.3 Germany 54
        7.3.4 France 55
        7.3.5 U.K. 55
        7.3.6 Italy 56
        7.3.7 Russia 56

 8 ASIA PACIFIC 57
    8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57
        8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57
        8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58
    8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59
        8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59
        8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60
    8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62
        8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62
        8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63
        8.3.3 China 65
        8.3.4 Japan 66
        8.3.5 Korea 67
        8.3.6 India 68
        8.3.7 Australia 69
        8.3.8 Southeast Asia 70

 9 LATIN AMERICA 71
    9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71
        9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71
        9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72
    9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73
        9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73
        9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74
    9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76
        9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76
        9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77
        9.3.3 Mexico 79
        9.3.4 Brazil 80
        9.3.5 Argentina 81

 10 MIDDLE EAST AND AFRICA 82
    10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82
        10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82
        10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83
    10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84
        10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84
        10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85
    10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87
        10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87
        10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88
        10.3.3 Middle East 89
        10.3.4 Africa 90

 11 CORPORATE PROFILE 91
    11.1 GeneHarbor 91
        11.1.1 GeneHarbor Corporation Information 91
        11.1.2 GeneHarbor Overview 91
        11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92
        11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92
        11.1.5 GeneHarbor Recent Developments 93
    11.2 Herbalmax 93
        11.2.1 Herbalmax Corporation Information 93
        11.2.2 Herbalmax Overview 93
        11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94
        11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94
    11.3 Genex Formulas 95
        11.3.1 Genex Formulas Corporation Information 95
        11.3.2 Genex Formulas Overview 95
        11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96
        11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96
    11.4 Shinkowa Pharmaceutical 97
        11.4.1 Shinkowa Pharmaceutical Corporation Information 97
        11.4.2 Shinkowa Pharmaceutical Overview 97
        11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98
        11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98
        11.4.5 Shinkowa Pharmaceutical Recent Developments 98
    11.5 Maac10 Formulas 99
        11.5.1 Maac10 Formulas Corporation Information 99
        11.5.2 Maac10 Formulas Overview 99
        11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100
        11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100
    11.6 EffePharm 101
        11.6.1 EffePharm Corporation Information 101
        11.6.2 EffePharm Overview 101
        11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101
        11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102
    11.7 Bontac 102
        11.7.1 Bontac Corporation Information 102
        11.7.2 Bontac Overview 103
        11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103
        11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104
        11.7.5 Bontac Recent Developments 104
    11.8 CELFULL 104
        11.8.1 CELFULL Corporation Information 104
        11.8.2 CELFULL Overview 105
        11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105
        11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105
    11.9 Kingdomway 106
        11.9.1 Kingdomway Corporation Information 106
        11.9.2 Kingdomway Overview 106
        11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107
        11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108

 12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109
    12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109
    12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109
        12.2.1 Key Raw Materials 109
        12.2.2 Raw Materials Key Suppliers 109
    12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110
    12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110
        12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110
        12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112
    12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113

 13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114
    13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114
    13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114
    13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115
    13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115

 14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116

 15 APPENDIX 117
    15.1 Research Methodology 117
        15.1.1 Methodology/Research Approach 117
        15.1.2 Data Source 120
    15.2 Author Details 122

Table 1. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) 1
Table 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) 2
Table 3. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 (US$ Million) 8
Table 4. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg) 9
Table 5. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022) 10
Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg) 10
Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2023-2028) 11
Table 8. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2023-2028) 11
Table 9. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (US$ Million) 12
Table 10. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2017-2022) 12
Table 11. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (US$ Million) 12
Table 12. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2023-2028) 13
Table 13. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2017-2022) & (Kg) 19
Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Manufacturers (2017-2022) 20
Table 15. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2017-2022) & (US$ Million) 22
Table 16. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers (2017-2022) 22
Table 17. Beta-Nicotinamide Mononucleotide (NMN) Price by Manufacturers 2017-2022 (USD/Kg) 23
Table 18. Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5) 24
Table 19. Global Beta-Nicotinamide Mononucleotide (NMN) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Nicotinamide Mononucleotide (NMN) as of 2021) 24
Table 20. Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base Distribution and Headquarters 25
Table 21. Date of Manufacturers Established 26
Table 22. Mergers & Acquisitions, Expansion Plans 26
Table 23. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 27
Table 24. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 27
Table 25. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2017-2022) 27
Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Type (2023-2028) 28
Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 28
Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 29
Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2017-2022) 29
Table 30. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2023-2028) 29
Table 31. Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) & (USD/Kg) 30
Table 32. Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) & (USD/Kg) 30
Table 33. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 32
Table 34. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 32
Table 35. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2017-2022) 33
Table 36. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Application (2023-2028) 33
Table 37. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 34
Table 38. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 34
Table 39. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2017-2022) 34
Table 40. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2023-2028) 35
Table 41. Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) & (USD/Kg) 36
Table 42. Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) & (USD/Kg) 36
Table 43. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 37
Table 44. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 37
Table 45. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 38
Table 46. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 38
Table 47. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 39
Table 48. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 40
Table 49. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 40
Table 50. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 41
Table 51. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg) 42
Table 52. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg) 42
Table 53. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million) 43
Table 54. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million) 43
Table 55. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 46
Table 56. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 46
Table 57. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 47
Table 58. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 47
Table 59. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 48
Table 60. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 49
Table 61. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 49
Table 62. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 50
Table 63. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg) 51
Table 64. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg) 51
Table 65. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million) 52
Table 66. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million) 52
Table 67. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 57
Table 68. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 57
Table 69. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 58
Table 70. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 58
Table 71. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 59
Table 72. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 60
Table 73. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 60
Table 74. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 61
Table 75. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2022) & (Kg) 62
Table 76. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2023-2028) & (Kg) 62
Table 77. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2022) & (US$ Million) 63
Table 78. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2023-2028) & (US$ Million) 63
Table 79. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 71
Table 80. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 71
Table 81. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 72
Table 82. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 72
Table 83. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 73
Table 84. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 74
Table 85. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 74
Table 86. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 75
Table 87. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg) 76
Table 88. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg) 76
Table 89. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million) 77
Table 90. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million) 77
Table 91. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2022) & (Kg) 82
Table 92. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2023-2028) & (Kg) 82
Table 93. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2022) & (US$ Million) 83
Table 94. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2023-2028) & (US$ Million) 83
Table 95. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2022) & (Kg) 84
Table 96. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2023-2028) & (Kg) 85
Table 97. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2022) & (US$ Million) 85
Table 98. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2023-2028) & (US$ Million) 86
Table 99. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2022) & (Kg) 87
Table 100. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2023-2028) & (Kg) 87
Table 101. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2022) & (US$ Million) 88
Table 102. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2023-2028) & (US$ Million) 88
Table 103. GeneHarbor Corporation Information 91
Table 104. GeneHarbor Description and Major Businesses 91
Table 105. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 92
Table 106. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92
Table 107. GeneHarbor Recent Developments 93
Table 108. Herbalmax Corporation Information 93
Table 109. Herbalmax Description and Major Businesses 93
Table 110. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 94
Table 111. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94
Table 112. Genex Formulas Corporation Information 95
Table 113. Genex Formulas Description and Major Businesses 95
Table 114. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 96
Table 115. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96
Table 116. Shinkowa Pharmaceutical Corporation Information 97
Table 117. Shinkowa Pharmaceutical Description and Major Businesses 97
Table 118. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 98
Table 119. Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98
Table 120. Shinkowa Pharmaceutical Recent Developments 98
Table 121. Maac10 Formulas Corporation Information 99
Table 122. Maac10 Formulas Description and Major Businesses 99
Table 123. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 100
Table 124. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100
Table 125. EffePharm Corporation Information 101
Table 126. EffePharm Description and Major Businesses 101
Table 127. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 101
Table 128. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102
Table 129. Bontac Corporation Information 102
Table 130. Bontac Description and Major Businesses 103
Table 131. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 103
Table 132. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104
Table 133. Bontac Recent Developments 104
Table 134. CELFULL Corporation Information 104
Table 135. CELFULL Description and Major Businesses 105
Table 136. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 105
Table 137. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105
Table 138. Kingdomway Corporation Information 106
Table 139. Kingdomway Description and Major Businesses 106
Table 140. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) 107
Table 141. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108
Table 142. Key Raw Materials Lists 109
Table 143. Raw Materials Key Suppliers Lists 109
Table 144. Beta-Nicotinamide Mononucleotide (NMN) Distributors List 112
Table 145. Beta-Nicotinamide Mononucleotide (NMN) Market Trends 114
Table 146. Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114
Table 147. Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115
Table 148. Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115
Table 149. Research Programs/Design for This Report 117
Table 150. Key Data Information from Secondary Sources 120
Table 151. Key Data Information from Primary Sources 121


List of Figures

Figure 1. Beta-Nicotinamide Mononucleotide (NMN) Product Picture 1
Figure 2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type in 2021 & 2028 2
Figure 3. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application in 2021 & 2028 3
Figure 4. Health Care Products 4
Figure 5. Cosmetics 4
Figure 6. Beta-Nicotinamide Mononucleotide (NMN) Report Years Considered 5
Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Sales 2017-2028 (Kg) 6
Figure 8. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue, (US$ Million), 2017 VS 2022 VS 2028 7
Figure 9. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue 2017-2028 (US$ Million) 8
Figure 10. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region in Percentage: 2021 Versus 2028 9
Figure 11. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2017-2022) 10
Figure 12. North America Beta-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg) 13
Figure 13. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million) 14
Figure 14. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg) 14
Figure 15. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million) 15
Figure 16. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg) 15
Figure 17. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million) 16
Figure 18. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg) 16
Figure 19. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million) 17
Figure 20. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales YoY (2017-2028) & (Kg) 17
Figure 21. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue YoY (2017-2028) & (US$ Million) 18
Figure 22. The Top 5 Players Market Share by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21
Figure 23. The Top 5 Players Market Share by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23
Figure 24. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 28
Figure 25. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 30
Figure 26. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33
Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 35
Figure 28. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 38
Figure 29. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 39
Figure 30. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 40
Figure 31. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 41
Figure 32. North America Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028) 43
Figure 33. North America Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028) 44
Figure 34. U.S. Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 44
Figure 35. Canada Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 45
Figure 36. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 47
Figure 37. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 48
Figure 38. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 49
Figure 39. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 50
Figure 40. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028) 52
Figure 41. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028) 53
Figure 42. Germany Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 54
Figure 43. France Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 55
Figure 44. U.K. Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 55
Figure 45. Italy Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 56
Figure 46. Russia Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 56
Figure 47. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 58
Figure 48. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 59
Figure 49. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 60
Figure 50. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 61
Figure 51. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Region (2017-2028) 63
Figure 52. Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Region (2017-2028) 64
Figure 53. China Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 65
Figure 54. Japan Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 66
Figure 55. Korea Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 67
Figure 56. India Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 68
Figure 57. Australia Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 69
Figure 58. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 70
Figure 59. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 72
Figure 60. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 73
Figure 61. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 74
Figure 62. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 75
Figure 63. Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028) 77
Figure 64. Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028) 78
Figure 65. Mexico Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 79
Figure 66. Brazil Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 80
Figure 67. Argentina Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 81
Figure 68. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 83
Figure 69. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 84
Figure 70. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 85
Figure 71. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 86
Figure 72. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Country (2017-2028) 88
Figure 73. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2017-2028) 89
Figure 74. Middle East Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 89
Figure 75. Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue (2017-2028) & (US$ Million) 90
Figure 76. Beta-Nicotinamide Mononucleotide (NMN) Value Chain 109
Figure 77. Channels of Distribution 111
Figure 78. Distributors Profiles 113
Figure 79. Bottom-up and Top-down Approaches for This Report 119
Figure 80. Data Triangulation 120
Figure 81. Key Executives Interviewed 122

Market Analysis and Insights: Global Beta-Nicotinamide Mononucleotide (NMN) Market
The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.

Global Beta-Nicotinamide Mononucleotide (NMN) Scope and Segment
Beta-Nicotinamide Mononucleotide (NMN) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company 
  GeneHarbor
  Herbalmax
  Genex Formulas
  Shinkowa Pharmaceutical
  Maac10 Formulas
  EffePharm
  Bontac
  CELFULL
  Kingdomway

Segment by Type
  Content ≥98%
  Content ＜98%

Segment by Application
Health Care Products
  Cosmetics
  Others

Segment by Region
North America
  U.S.
  Canada

  Asia-Pacific
  China
  Japan
  Korea
  India
  Australia
  Southeast Asia

  Europe
  Germany
  France
  U.K.
  Italy
  Russia

  Latin America
  Mexico
  Brazil
  Argentina

  Middle East and Africa
  Middle East
  Africa

Industry: Pharma & Healthcare

Published: 2022-06-28

Pages: 141 Pages

Report ld: 366851

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 4900.00

Multi Users License

USD 7350.00

Corporate Users License

USD 9800.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?